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Abstract— This paper primarily addresses a dataset relating 
to cellular, chemical and physical conditions of patients 
gathered at the time they are operated upon to remove 
colorectal tumours. This data provides a unique insight into the 
biochemical and immunological status of patients at the point of 
tumour removal along with information about tumour 
classification and post-operative survival. The relationship 
between severity of tumour, based on TNM staging, and 
survival is still unclear for patients with TNM stage 2 and 3 
tumours. We ask whether it is possible to predict survival rate 
more accurately using a selection of machine learning 
techniques applied to subsets of data to gain a deeper 
understanding of the relationships between a patient’s 
biochemical markers and survival.  
We use a range of feature selection and single classification 
techniques to predict the 5 year survival rate of TNM stage 2 
and 3 patients which initially produces less than ideal results. 
The performance of each model individually is then compared 
with subsets of the data where agreement is reached for multiple 
models. This novel method of selective ensembling demonstrates 
that significant improvements in model accuracy on an unseen 
test set can be achieved for patients where agreement between 
models is achieved. Finally we point at a possible method to 
identify whether a patients prognosis can be accurately 
predicted or not. 
 
Keywords—Ensemble, Bioinformatics, Machine 
Learning. 
1. INTRODUCTION 
olorectal cancer, commonly known as colon cancer or 
bowel cancer, is a form of cancer due to uncontrolled cell 
growth in the colon or rectum (parts of the large intestine), or 
in the appendix [1]; and is third most common cancer in men 
(663 000 cases, 10.0% of the total) and the second in women 
(571 000 cases, 9.4% of the total) worldwide. Around 60% 
of cases were diagnosed in the developed world. It is 
estimated that worldwide, in 2008, 1.23 million new cases of 
colorectal cancer were clinically diagnosed, and that there 
were 608,000 deaths due to this form of cancer, making it the 
fourth most common cause of death due to cancer [2].  
The colon or rectal cancers begin in the digestive system 
(also known as the gastro-intestinal system). The wall of 
colon and rectum are made up of layers of tissues. The cancer 
starts in the inner layer and grows through the other layers 
underneath through the bowel wall. The extent of a person’s 
cancer is commonly described using a TNM Cancer Staging 
system. The TNM staging system for all solid tumours was 
devised by Pierre Denoix to classify the progression of 
cancer, through the following three attributes:  
 
1. T describes the size of primary (original) Tumor and 
whether it has invaded nearby tissues 
2. N describes the involvement of nearby lymph Nodes  
3. M describes the spreading of cancer to other distant 
parts of the body (Metastasis)  
 
Based on the TNM stage and other biological factors such 
as age and health, subsequent treatment options are planned. 
However, patient prognosis is currently a poorly understood 
process. Though patients with a TNM stage of 1 or 4 have 
strong distinction with regard to predicting the survival 
period, those with TNM 2 & 3 stages have very poor 
C
prognosis accuracy, thus making TNM Stage a poor marker 
for prognosis. One current approach for predicting better 
survival rates combines the results of applying learning and 
anti-learning algorithms on a variety of physical, 
immunological, biochemical and clinical data collected from 
the patients after the tumour had been removed, combined 
with the TNM stage, and has been proven to yield better 
prognosis [3]. Anti-learning is the term given for the situation 
where performance of a trained computational intelligence 
technique is significantly worse than random guessing and is 
not overfitting or overtraining [4]. Anti-learning has been 
observed in a range of synthetic and real-world datasets [eg. 
16, 17, 18, 27] 
The data for this research was gathered by scientists and 
clinicians at City Hospital, Nottingham. The dataset we use 
here is made up of over 200 possible attributes for 462 
patients. The attributes are generated by recording metrics at 
the time of tumour removal, these include: 
 
• Physical data (age, sex etc)  
• Immunological data (levels of various T cell 
subsets)  
• Biochemical data (levels of certain proteins) 
• Retrospective data (post-operative survival 
statistics)  
• Clinical data (Tumour location, size etc.).  
 
In the research into the relationship between immune 
response and tumour staging there has been some support of 
the hypothesis that the adaptive immune response influences 
the behaviour of human tumours. In situ analysis of tumour-
infiltrating immune cells may therefore be a valuable 
prognostic tool in the treatment of colorectal cancer [5]. The 
immune and inflammation responses appear to have a role to 
play in the responses of patients to cancer [6] but the precise 
nature of this is still unclear.  
This research initially attempts to characterize the dataset 
and inter-relationships between attributes and then models 
cause effect relationships within the data using single and 
ensemble methods. We show that these tasks are extremely 
difficult using conventional techniques and that the dataset 
might belong to a subset of dataset that require a unique 
approach. We do this by using a range of supervised methods 
in an attempt to characterize features of the dataset and 
accommodate inadequacies such as missing data. 
2. MACHINE LEARNING AND ANTI-LEARNING TO 
PREDICT TNM STAGE FROM PATIENT DATA 
The meaningfulness of nearest neighbour style clustering 
in highly dimensional data has be discussed previously [7] 
and it can be argued that there are serious problems with 
using this approach alone. [8]. A supervised approach has 
more scope for reducing the dimensionality within the 
algorithm. It is relatively trivial to build a model that best fits 
the data, even with numerous attributes and missing values.  
Unfortunately this model is very likely to be memorising 
unique combinations of values for each patient. This is why 
models are tested on an unseen test set to decide how well the 
trained model generalises to the “rest of the world”. Here we 
attempt to build a testable model that predicts the TNM stage 
of a patient from the other available data. If we can more 
clearly define the relationship between physical TNM staging 
and the biochemical state of a patient we can hypothesise that 
treating a patient’s biochemical state with methods such as 
chemotherapy, immunotherapy and radiotherapy based on 
TNM stage is valid.  
Several methods were used in an attempt to predict the 
appropriate TNM stage of a patient from their attribute set. 
The methods used included Bayesian Networks [9], Naïve 
Bayes Classifier [10], Classification and Regression Trees 
(CART) [11], Multilayer Perceptron [12] and Support Vector 
Machines (SVM) [13]. These were either self-programmed, 
available in the R packages or the WEKA toolkit [14] or used 
other existing software suites [15].  
When initially looking at all 4 TNM stages there was some 
success at predicting stages from the attribute set, particularly 
when some of the patients and attributes with the most 
missing data were removed. Most success was achieved when 
predicting TNM stage 1 and 4, which were the least and most 
severe stages respectively [16]. Differentiating between 
TNM stage 2 and 3 using available patient data was a much 
more complicated task but modelling the relationship 
between patients data and TNM these 2 important tumour 
stages was best achieved using the inverse of the model 
prediction and exploiting the anti-learning phenomena. We 
compared a range of classifiers and attribute selection 
methods and consistently found test set performances of 
worse than guessing. It must be remembered that approaches 
were optimized for test set performance and performance of 
the training set was much better (80-98% accurate).  This 
kind of behaviour is rare but dataset types it has been 
observed in include biological data in general and cancer data 
in particular [28].  
 
We arrive at the following set of facts: 
 Some functions are best modelled using a machine 
learning approach 
 Some functions are best modelling using a machine 
anti-learning approach 
 Some cause-effect relationships are the aggregate of 
many individual functions 
 
It is logical to therefore conclude that some data modelling 
tasks will be ideally implemented using both learning and 
anti-learning approaches on relevant subsets of the data. For 
instance, both hadamard matrices [17] and simple polynomial 
functions (eg. A=x+(1/y)-z) are 100% solvable by simple 
anti-learning and learning methods (eg. SVM, Multilayer 
Perceptron) respectively but if you merge these datasets and 
attempt to predict the XOR of the 2 outputs results fall 
dramatically to approximately 50% regardless of if you take 
an anti-learning or learning approach.  
 
3. SUPERVISED ENSEMBLE LEARNING OF SURVIVAL 
RATES 
 We have detailed information about post-operative 
survival, so we can also model how attribute values effect 
survival rates. Several of the physical attributes available in 
the dataset pertain to the survival of the patients after their 
operation to remove the tumour. The number of months the 
patient has survived, whether they are still alive or not and 
how they died are all available. Figure 1 shows survival 
curves for patients up to 60 months, after which, clinicians 
deem they have ‘survived’ their colorectal tumour. The 
strong difference between survival rates in TNM stage 1 and 
4 patients is apparent (i.e. at 30 month the survival rate is 
approximately 95% and 5% for these 2 groups). The 
difference between patients with TNM stage 2 and 3 cancers 
is less apparent.  
 
 
 
Figure 1. Survival Curves for patients at all 4 TNM stages 
 
Again focusing on just TNM stage 2 and 3 patients we 
attempted to predict survival using both AI techniques and 
the TNM stage itself. The term “survival” is somewhat 
subjective but for the purposes of this work we used 5 years 
as the threshold for survival. Using the TNM stage alone to 
predict survival gives an accuracy of 64.6% (155 correct from 
240). This is achieved by stating that all type 2 tumour 
patients will survive and all type 3 will not.   
Due to the high dimensionality of the data using the entire 
dataset yields very poor results [16] so a degree of attribute 
selection is required. To achieve this, the dataset was ranked 
based on four evaluators, and the top ten attributes were used 
in training various models. The results of the experiments are 
shown in Figure 2. Accuracy is used here and throughout this 
paper as it is the most transparent measurement when positive 
and negative outcomes are close to equivalent, as they are 
here. Also, all results shown are for the unseen test data via 
10 fold cross validation. It can be clearly seen that the SVM 
ranking [19] works best across various algorithms. For SMO 
and PegaSOS (both based on Support Vector Machines), 
SVM Ranking is clearly the better ranker. However, it is 
interesting to note that the SVM Ranked attributes perform 
best in decision trees, and other algorithms as well. The 
ChiSquared [20] and InfoGain [21] attribute evaluators have 
the same best 10 attributes, but ranked in a different order. 
However, for the learner, these two rankings are the same and 
hence they have the same prediction accuracies.  Based on 
the graph in Figure 2 and the trial experiments, SVM ranking 
emerged undisputedly as the best ranking algorithm for this 
sample dataset. The best 10 attributes and the worst 10 
attributes based on SVM Ranking are listed in Table 1, it was 
felt that taking the highest and lowest 10 values was sufficient 
to create subsets.   A detailed description what these markers 
represent is beyond the scope of this paper but all have some 
relevance to a patients cancer situation. 
  
Experiments were conducted with the SVM Ranked data 
sample, to decide on the algorithms to work as an ensemble. 
The final list of algorithms used is –  
 
• SVM (Sequential Minimal Optimization) [22]  
• Logistic Regression [23]  
• Classification and Regression Trees [11]  
• J48 trees [24]  
 
Experiments were also conducted to learn on the anti-
learnable properties of the data.  
 
 
Figure 2. Comparison of Evaluators 
 
Using the SVM (SMO) algorithm as an example, the best 
10 and the worst 10 attributes were used to train the machine 
learning algorithm, using a leave-one-out cross validation. 
The results for various algorithms on using the worst 10 
(table 2) and best 10 (table 3) attributes are tabulated below. 
The primary objective of this exercise is to find the optimum 
number of attributes that can be used for training the learning 
algorithms.   
 
 
 
TABLE 1 
BEST AND WORST TEN ATTRIBUTES BASED ON SVM RANKING 
 
 
TABLE 2 
SVM (SMO) ALGORITHM WORST PERFORMING ATTRIBUTES 
 
 
TABLE 3 
SVM (SMO) ALGORITHM BEST PERFORMING ATTRIBUTES 
 
 
Using the best 8 attributes clearly gives maximum 
prediction accuracy on the dataset. Using the worst 8 
attributes, SVM gives the worst prediction accuracy of 
41.66%, which, on performing the negation, will lead to the 
maximum prediction accuracy. Similar experiments were 
carried out using other algorithms to decide the optimal 
number of attributes. The final list of algorithms is –   
  
• Simple CART – TNM Staging  
• SVM(SMO) – Best 8 attributes  
• SVM(SMO) – Worst 8 attributes   
• Logistic – Best 8 attributes  
• Logistic – Worst 9 attributes  
• J48 – Best 8 attributes  
 
 The ensemble has been constructed to use a logical AND 
function to vote on the class of the input sample, this is 
mathematically trivial but allows for novel and powerful 
aggregation of decisions. The ensemble consists of all 
possible subsets for 6 algorithms. This gives a total of 63 
possible combinations, inclusive of single algorithm results 
and a combination of all 6 algorithms. The 63 combinations 
consists of the following subsets –   
  
• 6 – single algorithms  
• 15 – 2 algorithm combinations  
• 20 – 3 algorithm combinations  
• 15 – 4 algorithm combinations  
• 6 – 5 algorithm combinations  
• 1 – combination of all 6 algorithms  
  
Figure 3 displays the prediction accuracies of the ensemble 
alongside the number of matches for that particular ensemble, 
with the number of algorithms used on the X axis. In this case 
‘number of matches’ means how many patients achieved 
agreement on the outcome. Obviously when only 1 algorithm 
is used all patients are included, as more algorithms are 
compared, agreement is less usual. It is to be expected that 
the number of matching results decreases in a regular fashion 
as the number of algorithms increase in the ensemble as 
complete agreement becomes less likely. It is also observable 
that as the number of algorithms in the ensemble increases 
there is a general increase in prediction accuracy from 
approximately 60-65% to nearly 90%.  This increase in 
accuracy is accompanied by a decrease in the number of 
patients this accuracy is achievable for. 
Best 10 attributes  Worst 10 attributes  
age  pERK  
IL17tc  FLIP  
p27cyto  ki67  
nucint2  cxcl9lowhigh  
Tstroma  cd46  
CXCR4xtilelovsho  micarec  
ulbp23  socs1  
cCD24ordrec  betcytop  
IRF2  betmembr  
statcyto.int  FLIPsCyto  
Number of Attributes  SVM Anti-Learning  
10  43.33  
9  45.83  
8  41.66  
7  47.91  
6  45  
5  50.41  
4  47.08  
3  48.75  
2  51.25  
1  52.91  
Number of Attributes  SVM Learning  
10  62.08  
9  63.33  
8  64.58  
7  62.5  
6  62.5  
5  62.08  
4  62.08  
3  57.08  
2  60  
1  49  
Figure 3. Number of Matches and Prediction Accuracy vs Ensemble size 
  
A graph of the prediction accuracies of the various 
ensembles is presented in Figure 4. The highest prediction 
accuracy of 89.66% is achieved by combining all algorithms 
apart from the predictions of best 8 attributes using SVM. 
However, as shown in figure 3 the five above mentioned 
algorithms agree for only 29 data samples. 
 
 
Figure 4. Prediction Accuracies of Ensemble 
 
As a final experiment we looked at the biomarker statistics 
for patients who had complete agreement for all six 
algorithms and compared them to patients where the decision 
on prognosis was most diverse, namely, 3 algorithms 
predicted survival over 5 years and 3 predicted survival 
under 5 years. Those where there was complete agreement 
of algorithms were deemed to have a higher ‘ease of 
prognosis’ value. The best single biomarker for predicting the 
‘ease of prognosis’ was ulbp3rec. ULBPs activate signaling 
pathways in primary Natural Killer cells,  
 
 
resulting in the production of cytokines and chemokines. It 
appears that when this variant is present a patient’s survival  
rate is more difficult to predict. Based on a 0 or 1 scoring 
mechanism, ulbp3rec is present at an average rate of 0.6111  
on patients that our ensemble couldn’t agree on vs 0.1877 for 
patients where all six ensemble algorithms agree. Identifying 
‘difficult’ patients using this method is about 72% accurate. 
If we add two other markers (Tstroma and p53) and use a 
simple MLP we can achieve a slightly higher 83% accuracy 
in predicting ‘difficult’ patients. This final analysis is on a 
relatively small number of patients (36) and is indicative 
rather than conclusive at this stage. 
 
To show how new survival predictions models compare to 
conventional methods of survival prediction, the dataset can 
be divided into 4 distinct subgroups, each with a 
corresponding survival rate: 
 
1. TNM 2 patients predicted to survive by the 
ensemble learning model. (TNM 2/model = survive) 
2. TNM 2 patients predicted not to survive by the 
ensemble learning model (TNM 2/model = not survive) 
3. TNM 3 patients predicted to survive by the 
ensemble learning model (TNM 3/model = survive) 
4. TNM 3 patients predicted not to survive by the 
ensemble learning model (TNM 3/model = not survive) 
 
One interesting observation about this is that survival of 
TNM stage 3 patients with a positive prognosis from the 
model have a better survival rate than TNM 2 patients with a 
negative prognosis. This is shown more clearly by plotting 
the 4 corresponding survival curves (fig. 5) 
Ensemble Size 
 
Figure 5. Survival curves for 4 distinct patient sets grouped on TNM stage 
and model prognosis 
4. DISCUSSION 
 We have presented results of a systematic analysis of a 
unique dataset based on a range of factors associated with 
colorectal tumour patients. This dataset is limited in many 
ways, but extremely important nonetheless and modeling any 
relationships or features based on the dataset to hand is an 
urgent priority. Generally, whether attempting to predict 
TNM stages or survival, patients at TNM stage 1 and 4 have 
more clear indicators in the attribute set. TNM stage 2 and 3 
patients provide a much more challenging prediction task, so 
much so that the TNM stage appears much less important 
when predicting survival for these 2 stages than other 
indicators.  The fact that prediction of survival can be 
achieved at comparable rates to TNM staging suggests that 
survival is actually based on BOTH the physical metrics used 
for TNM staging AND the biochemical and immunological 
markers presented at the time of tumorectomy.    
Rule tree, Bayesian and Neural approaches have been used 
with some limited success for prediction, but in most 
experiments there is a lack of repeatable success in 
developing a model that accurately predicts survival or TNM 
stage on an unseen test set. One possible reason for this could 
be over-fitting, though a well-constructed ANN or CART tree 
shouldn’t exhibit over fitting and in any case they shouldn’t 
be WORSE than guessing. Another possibility is poor or 
inaccurate labelling of patients tumour stages. But again this 
should only result in poor performance on the unseen test set.  
Methods such as Correlated Activity Pruning [25] may be 
useful in ensuring a minimal sized model and will be one 
focus of future research. There might be improvement to 
learning by using recent advancements such as multiple 
kernel learning [26] but it is just as likely, as with boosting, 
methods that improve learning may be just as effective at 
amplifying values in the opposite direction. Overall this is an 
iterative process with a large number of steps, each providing 
more insight into the dataset and its modeling. There is 
substantial pre-processing required and it is significant that 
pre-processing the patient’s data (selecting based on different 
thresholds) has a significant difference on the resulting 
models.  
This failure to accurately classify TNM stages or survival 
periods may in fact be useful if we suspect there are subsets 
within the groups. The failure to correctly classify a set of 
patients may mean these patients have different 
characteristics while still expressing the same classification 
of tumour. This would imply that treatment based solely on 
tumour classification would be sub-optimal.  
We have proposed an explanation for the results which is 
a phenomenon called “Anti-learning”. Here, unique 
characteristics of the dataset lead to a condition where 
validation on an unseen test set produces results significantly 
and repeatedly worse than guessing. Interestingly, one real 
world dataset that demonstrates this behavior is very similar 
to the dataset used here, being the classification of response 
to chemo/radiotherapy in Esophageal Adenocarcinoma 
patients using microarray data of biopsied patients [27] [28]. 
It is possible to then infer that with some highly dimensional 
complex biological data sets, when we have a relatively small 
sample size, anti-learning exists. Initial experiments appeared 
to show that the best possible approach to classifying patients 
with TNM stage 2 and 3 tumours was to focus on anti-
optimizing the learning process to achieve the worse possible 
test set performance and then inverting the underlying model. 
Overall when looking for test set performance on the 
important TNM stage 2 and 3 patients, the best possible 
results can be achieved if we inverted the answer supplied by 
an ADABoosted SVM or ANN. Using these methods it is 
possible to achieve reliable prediction rates on an unseen test 
set of higher than any learning algorithm attempted. It is not 
impossible to imagine that many complex biological datasets 
also present us with a small, noisy sample of a much bigger 
complex dataset and this must be investigated further. The 
dataset used here has several drawbacks when it comes to 
building robust cause-effect models. The 2 main issues are 
the missing values and the high dimensionality.  
By pre-processing the dataset to convert attributes that may 
have a non-linear effect into linear attributes, missing values 
can be represented as means of all values with a more stable 
meaning. This pre-processing step also makes resulting 
machine learning approaches more capable of reaching 
global minima. The second issue of high dimensionality is 
tackled by using an attribute selection approach first 
demonstrated on another cancer dataset. We not only use the 
most highly ranked attributes here but by using anti-learning 
on the lowest ranked attributes we can produce other, distinct 
models of the data.  
When looking specifically at survival, using 3-6 unique 
predictive approaches allows us to compare predictions from 
all these approaches. The significant amount of differences 
between the predictions for these approaches could be 
inferred from the lack of relationships between TNM staging 
and the immunohistochemistry [16] and the lack of a 
relationship between unsupervised clusters and TNM stages 
[7]. The introduction of anti-learning methods to the 
ensemble approach also makes for a diverse set of algorithms 
capable of modeling complex relationships. So for the set of 
patients, the level of agreement can fall to as low as 10% but 
when agreement occurred, predictive performance increased 
up to a maximum of 90%. This level of accuracy for 
predicting survival of patients with TNM stage 2 and 3 
tumours is unprecedented, albeit on a small subset of patients. 
5. CONCLUSIONS 
In this paper we show that the relationship between clinical 
markers, physical tumour characteristics and patient survival 
is a complex one, but using a range of preprocessing, machine 
learning and ensemble learning approaches we make 
significant improvements in the predictability of survival. 
The ensemble learning approach offers an important 
opportunity for clinicians to improve and customise 
prognosis for patients but also, any information gained by 
analysing the agreeing models can be fed back to researchers 
in their endeavors to improve treatment options at a cellular 
level. It is apparent that small changes to the pre-processing 
mechanisms can yield significant changes to the ensemble 
learning accuracy but due to the highly dimensional nature of 
the data, optimising and automating the pre-processing and 
feature selection stage is currently a subject of further 
research. We also show for the first time that inverse ranking 
methods are an efficient method for attribute selection for 
anti-learning methods. Our ensemble learning models show 
the highest accuracy so far seen in predicting survival in 
patients, albeit a subset of patients. 
Real world datasets sometimes consist of multiple 
relationships with differing degrees of learnability. If we can 
deconstruct these datasets into solvable sub-components we 
will be making a huge leap in tackling real world complex 
and big data modelling tasks. 
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